Investigación / Grupos de investigación

Grupo  2

Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Publicaciones (372)

  • Garcia-Alvarez, M; Berenguer, J; Jimenez-Sousa, MA; Pineda-Tenor, D; Aldamiz-Echevarria, T; Tejerina, F; Diez, C; Vazquez-Moron, S; Resino, S.

    Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study

    Scientific Reports. 2017; 7: Nº de citas: 22 [doi:10.1038/srep41516]

  • Karpov, I; Vassilenko, A; Skrahina, A; Klimuk, D; Skrahin, A; Kondratenko, O; Zalutskaya, A; Bondarenko, V; Mitsura, V; Kozorez, E; Tumash, O; Suetnov, O; Paduto, D; Iljina, V; Kummik, T; Bolokadze, N; Mshvidobadze, K; Lanchava, N; Goginashvili, L; Mikiashvili, L; Bablishvili, N; Rozentale, B; Zeltina, I; Janushkevich, I; Caplinskiene, I; Caplinskas, S; Kancauskiene, Z; Podlasin, R; Wiercinska-Drapalo, A; Thompson, M; Kozlowska, J; Grezesczuk, A; Bura, M; Knysz, B; Inglot, M; Garlicki, A; Loster, J; Duiculescu, D; Tetradov, S; Rakhmanova, A; Panteleeva, O; Yakovlev, A; Kozlov, A; Tyukalova, A; Vlasova, Y; Panteleev, A; Trofimova, T; Borodulina, E; Vdoushkina, E; Borodulina, E; Kyselyova, G; Obel, N; Thorsteinsson, K; Payen, MC; Kabeya, K; Necsoi, C; Dabis, F; Bruyand, M; Morlat, P; Dupont, A; Gerard, Y; Bonnal, F; Ceccaldi, J; De Witte, S; Monlun, E; Lataste, P; Chossat, I; Sagette, M; Rickenbach, M; Elzi, L; Battegay, M; Furrer, H; Sculier, D; Calmy, A; Cavassini, M; Bruno, A; Bernasconi, E; Hoffmann, M; Vernazza, P; Fehr, J; Weber, R; Miller, RF; Vora, N; Cooke, G; Mullaney, S; Wilkins, E; George, V; Collini, P; Dockrell, D; Post, F; Campbell, L; Brum, R; Mabonga, E; Saigal, P; Kegg, S; Ainsworth, J; Waters, A; Dhar, J; Mashonganyika, L; Girardi, E; Rianda, A; Galati, V; Pinnetti, C; Tommasi, C; Lapadula, G; Di Biagio, A; Parisini, A; Carbonara, S; Angarano, G; Purgatorio, M; Matteelli, A; Apostoli, A; Miro, JM; Manzardo, C; Ligero, C; Gonzalez, J; Martinez-Martinez, JA; Sanchez, F; Knobel, H; Salvado, M; Lopez-Colomes, JL; Martinez-Lacasa, X; Cuchi, E; Falcoo, V; Curran, A; Tortola, MT; Ocana, I; Vidal, R; Sambeat, MA; Pomar, V; Coll, P; Pozamczer, D; Saumoy, M; Alcaide, F; Cayla, J; Moreno, A; Millet, JP; Orcau, A; Fina, L; Romero, A; Roldan, LL; Iribarren, JA; Ibarguren, M; Moreno, S; Gonzalez, A; Miralles, P; Aldamiz-Echevarria, T; Losso, M; Toibaro, J; Gambardella, L; Toibaro, J; Macias, LM; Warley, E; Tavella, S; Messina, OG; Gear, O; Laplume, H; Marson, C; Contarelia, J; Michaan, M; Scapellato, P; Alessandro, DD; Bartoletti, B; Palmero, D; Elias, C; Cortes, C; Crabtree, B; Gomez, JLM; Villanueva, JA; Hernandez, LAG; Badial, F; Furrer, H; Girardi, E; Bruyand, M; Cayla, JA; Losso, M; Lundgren, JD; Panteleev, A; Miller, RF; Miro, JM; Obel, N; Duiculescu, D; Post, FA; Skrahin, A; Toibaro, J; Schultze, A; Mocroft, A; Efsen, AMW; Mansfeld, M; Aagaard, B; Nielsen, BR; Fisher, AH; Larsen, JF; Raben, D; Podlekareva, DN; Kirk, O; Podlekareva, DN; Schultze, A; Panteleev, A; Skrahina, AM; Miro, JM; Rakhmanova, A; Furrer, H; Losso, MH; Toibaro, J; Vassilenko, A; Girardi, E; Lundgren, JD.

    One-year mortality of HIV-positive patients treated for rifampicin-and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America

    AIDS. 2017; 31(3): 375-384 Nº de citas: 9 [doi:10.1097/QAD.0000000000001333]

  • Wang, Q; De Luca, A; Smith, C; Zangerle, R; Sambatakou, H; Bonnet, F; Smit, C; Schommers, P; Thornton, A; Berenguer, J; Peters, L; Spagnuolo, V; Ammassari, A; Antinori, A; Roldan, EQ; Mussini, C; Miro, JM; Konopnicki, D; Fehr, J; Campbell, MA; Termote, M; Bucher, HC.

    Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients

    ANNALS OF INTERNAL MEDICINE. 2017; 166(1): 9 Nº de citas: 43 [doi:10.7326/M16-0240]

  • de la Calle, GM; Pulido, F; Sanchez-Conde, M; de Quiros, JCLB.

    Long-term comparative and prospective cohort study of renal function in patients with HIV infection treated with tenofovir disoproxil fumarate

    HIV & AIDS REVIEW. 2017; 16(2): 77-83 Nº de citas: 1 [doi:10.5114/hivar.2017.66859]

  • Micozzi, S; Perez-Ezquerra, PR; Morales-Cabeza, C; Diez, C; De Barrio, M.

    Stevens Johnson Syndrome versus Jarisch Herxheimer Reaction in an HIV Positive Patient with Secondary Syphilis

    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY. 2017; 11(2): 125-128 [doi:10.2174/1872213X11666171026111648]

  • Pozniak, A; Flamm, J; Antinori, A; Bloch, M; Ward, D; Berenguer, J; Cote, P; Andreatta, K; Garner, W; Szwarcberg, J; Nguyen-Cleary, T; McColl, DJ; Piontkowsky, D.

    Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI

    HIV CLIN TRIALS. 2017; 18(4): 141-148 Nº de citas: 16 [doi:10.1080/15284336.2017.1338844]

  • Gallant, J; Moyle, G; Berenguer, J; Shalit, P; Cao, HY; Liu, YP; Myers, J; Rosenblatt, L; Yang, LF; Szwarcberg, J.

    Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial

    CURRENT HIV RESEARCH. 2017; 15(3): 216-224 Nº de citas: 5 [doi:10.2174/1570162X14666161021102728]

  • Lois, TAE; Lopez-Polin, A; Norman, FF; Monge-Maillo, B; Lopez-Velez, R; Perez-Molina, JA.

    Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: Report on the experience of a referral centre for tropical infections in Spain

    Travel Medicine and Infectious Disease. 2017; 15: 52-56 Nº de citas: 15 [doi:10.1016/j.tmaid.2016.10.013]

  • Bouteloup, V; Sabin, C; Mocroft, A; Gras, L; Pantazis, N; Le Moing, V; d'Arminio Monforte, A; Mary-Krause, M; Roca, B; Miro, J; Battegay, M; Brockmeyer, N; Berenguer, J; Morlat, P; Obel, N; De Wit, S; Fatkenheuer, G; Zangerle, R; Ghosn, J; Perez-Hoyos, S; Campbell, M; Prins, M; Chene, G; Meyer, L; Dorrucci, M; Torti, C; Thiebaut, R.

    Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients

    HIV MEDICINE. 2017; 18(1): 33-44 Nº de citas: 16 [doi:10.1111/hiv.12389]

  • Laguno, M; Von Wichmann, MA; Van den Eynde, E; Navarro, J; Cifuentes, C; Murillas, J; Veloso, S; Martinez-Rebollar, M; Guardiola, JM; Jou, A; Gomez-Sirvent, JL; Cervantes, M; Pineda, JA; Lopez-Calvo, S; Carrero, A; Montes, ML; Deig, E; Tapiz, A; Ruiz-Mesa, JD; Cruceta, A; de Lazzari, E; Mallolas, J.

    Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study

    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2016; 53: 46-51 Nº de citas: 1 [doi:10.1016/j.ijid.2016.10.028]

  • Troya, J; Ryan, P; Ribera, E; Podzamczer, D; Hontanon, V; Terron, JA; Boix, V; Moreno, S; Barrufee, P; Castano, M; Carrero, A; Galindo, MJ; Suarez-Lozano, I; Knobel, H; Raffo, M; Solis, J; Yllescas, M; Esteban, H; Gonzalez-Garcia, J; Berenguer, J; Imaz, A.

    Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

    PLoS One. 2016; 11(10): Nº de citas: 7 [doi:10.1371/journal.pone.0164455]

  • Estrada, V; Monge, S; Gomez-Garre, MD; Sobrino, P; Masia, M; Berenguer, J; Portilla, J; Vilades, C; Martinez, E; Blanco, JR.

    Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy

    HIV MEDICINE. 2016; 17(9): 653-661 Nº de citas: 20 [doi:10.1111/hiv.12368]

  • Medrano, LM; Rallon, N; Berenguer, J; Jimenez-Sousa, MA; Soriano, V; Aldamiz-Echevarria, T; Fernandez-Rodriguez, A; Garcia, M; Tejerina, F; Martinez, I; Benito, JM; Resino, S.

    Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

    JOURNAL OF TRANSLATIONAL MEDICINE. 2016; 14: Nº de citas: 20 [doi:10.1186/s12967-016-1005-7]

  • Jimenez-Sousa, MA; Berenguer, J; Rallon, N; Pineda-Tenor, D; Aldamiz-Echevarria, T; Soriano, V; Garcia-Alvarez, M; Vazquez-Moron, S; Restrepo, C; Carrero, A; Benito, JM; Resino, S.

    IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection

    LIVER INTERNATIONAL. 2016; 36(9): 1258-1266 Nº de citas: 9 [doi:10.1111/liv.13079]

  • Rivero, A; Polo, R; Aldeguer, JL; Lozano, F; Antela, A; Aguirrebengoa, K; Arribas, JR; Asensi, V; Berenguer, J; Blanco, JR; Boix, V; Casado, JL; Clotet, B; Crespo, M; Domingo, P; Duenas, C; Estrada, V; Garcia, F; Gatell, JM; Gomez-Sirvent, JL; Gonzalez-Garcia, J; Gutierrez, F; Iribarren, JA; Knobel, H; Llibre, JM; Losa, JE; Mallolas, J; Marino, A; Miro, JM; Moreno, S; Palacios, R; Pineda, JA; Pulido, F; Ribera, E; Rubio, R; Moreno, JS; Sanz, JS; Tellez, MJ; de la Torre, J; Tuset, M; Molina, JAP.

    Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2016)

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2016; 34(7): 439-451 Nº de citas: 12 [doi:10.1016/j.eimc.2016.02.028]

  • Berenguer, J; Rivero, A; Blasco, AJ; Arribas, JR; Boix, V; Clotet, B; Domingo, P; Gonzalez-Garcia, J; Knobel, H; Lazaro, P; Lopez, JC; Llibre, JM; Lozano, F; Miro, JM; Podzamczer, D; Tuset, M; Gatell, JM.

    Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2016; 34(6): 361-371 Nº de citas: 7 [doi:10.1016/j.eimc.2015.07.012]

  • Neukam, K; Espinosa, N; Collado, A; Delgado-Fernandez, M; Jimenez-Aguilar, P; Rivero-Juarez, A; Hontanon-Antonana, V; Gomez-Berrocal, A; Ruiz-Morales, J; Merino, D; Carrero, A; Tellez, F; Rios, MJ; Hernandez-Quero, J; de Lagarde-Sebastian, M; Perez-Camacho, I; Vera-Mendez, F; Macias, J; Pineda, JA.

    Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

    PLoS One. 2016; 11(5): Nº de citas: 7 [doi:10.1371/journal.pone.0155842]

  • Garcia-Alvarez, M; Berenguer, J; Jimenez-Sousa, MA; Vazquez-Moron, S; Carrero, A; Gutierrez-Rivas, M; Aldamiz-Echevarria, T; Lopez, JC; Garcia-Broncano, P; Resino, S.

    Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients

    AIDS. 2016; 30(7): 1069-1074 Nº de citas: 7 [doi:10.1097/QAD.0000000000001007]